Revance Therapeutics Inc. buy michaelkr
Start price
09.12.24
/
50%
€3.66
Target price
09.12.25
-
Performance (%)
-19.67%
End price
22.12.24
€2.94
Summary
This prediction ended on 22.12.24 with a price of €2.94. The prediction for Revance Therapeutics Inc. disappointed with a performance of -19.67%. michaelkr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by michaelkr for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.